Back to results
US 2012/0252738 A1Published application
Tubulin Inhibitors
AssigneeR&D-Biopharmaceuticals GmbH
InventorWolfgang Richter
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel tubulin binding molecules of formula (I) and their use for the treatment of cancer and other diseases.
Claims13
Compound of formula (I):
- wherein
- R is H, an alkyl, alkenyl, alkynyl, CO-alkyl, heteroalkyl, aralkyl or heteroaralkyl group, all of which may optionally be substituted;
- R′ is OH, an alkyl, alkenyl, alkynyl, —O—CO-alkyl or heteroalkyl group, all of which may optionally be substituted;
- R″ is a group of formula CO2H, CO2R′″, CONHR′″, CONR2′″, with R′″ independently being an alkyl, aryl, aralkyl or heteroalkyl group;
- X is S or O;
- Y is independently optionally substituted alkyl, optionally substituted heteroalkyl, halogen, CN, NO2 or OH;
- n is 0, 1, 2, 3, 4 or 5;
- or a pharmacologically acceptable salt, solvate, hydrate or a pharmacologically acceptable formulation thereof.
5 more elements
11-12. (canceled)
Dependencies are inferred from the claim text.